• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Biotech Market
    Biotech News
    Biotech Stocks
    • Biotech Market
    • Biotech News
    • Biotech Stocks

    Provectus Biopharmaceuticals Changes Date of Quarterly Business Update Conference Call

    Vivien Diniz
    Mar. 10, 2016 09:47AM PST
    Biotech Investing

    Provectus Biopharmaceuticals, Inc. (NYSEMKT:PVCT) today announce that it is changing the date for its fourth quarter and year-end conference call to Wednesday March 16, 2016, from March 10, 2016. The call will take place at 4 pm EDT that day.

    Provectus Biopharmaceuticals, Inc. (NYSEMKT:PVCT) today announce that it is changing the date for its fourth quarter and year-end conference call to Wednesday March 16, 2016, from March 10, 2016. The call will take place at 4 pm EDT that day.
    According to the news:

    The Company is rescheduling the call to coincide with the filing of its Annual Report on Form 10-K with the SEC expected to occur on Tuesday March 15, 2016. The Company believes that the change will enable more comprehensive discussion from the Company to stockholders during the conference call on Wednesday March 16th. Further, it will permit CTO Eric Wachter, who is traveling, to participate in the call and answer questions from stockholders regarding the development of the Company’s investigational drug candidates.

    Click here to view the full press release.

    drug-candidatesconference-call
    The Conversation (0)

    Go Deeper

    AI Powered
    Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

    Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

    ImmunoGen, Inc. Announces Conference Call to Discuss Financial Results

    Latest News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Biotech Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES